Dumadaug, Eriberto F.
HRN: 21-56-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2025
CEFTAZIDIME 1GM (VIAL)
01/20/2025
01/27/2025
IV
1g
Q8
DM FOOT
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes